Showing results (1651-1660 of 1,770) with videos related to

Sort By:
Pageof 177
Cancer Research|February 24, 2011
Integrative genomics identifies molecular alterations that challenge the linear model of melanoma progressionAmy E Rose, Laura Poliseno, Jinhua Wang, et al.
Mbio|June 26, 2025
Host-specific adaptation in Fusarium oxysporum correlates with distinct accessory chromosome content in human and plant pathogenic strainsDilay Hazal Ayhan, Serena Abbondante, Domingo Martínez-Soto, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2026
Outcomes associated with empiric azithromycin use among patients hospitalized with non-severe community-acquired pneumonia: emulation of a target trialAshwin B Gupta, Emily Walzl, David Ratz, et al.
Biorxiv : the Preprint Server for Biology|December 19, 2025
Engineering immunotoxin-equipped effector cells and evaluation in primary human immune cellsAlexander H Pearlman, Brian J Mog, Michael S Hwang, et al.
Trends in Genetics : TIG|May 30, 2001
Paramecium genome survey: a pilot projectP Dessen, M Zagulski, R Gromadka, et al.
Brain Research|June 12, 2024
Alzheimer's-linked axonal changes accompany elevated antidromic action potential failure rate in aged miceMatthew L Russo, Gelique Ayala, Demetria Neal, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2026
Lethal toxin-equipped effector cells for the potential treatment of cancerAlexander H Pearlman, Brian J Mog, Michael S Hwang, et al.
Investigative Ophthalmology & Visual Science|February 28, 2002
Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growthElia J Duh, Hoseong S Yang, Izumi Suzuma, et al.
JAMA Oncology|March 30, 2018
Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal CancerHeather Hampel, Rachel Pearlman, Mallory Beightol, et al.
Gynecologic Oncology|March 9, 2023
MLH1-methylated endometrial cancer under 60 years of age as the "sentinel" cancer in female carriers of high-risk constitutional MLH1 epimutationMegan P Hitchins, Rocio Alvarez, Lisa Zhou, et al.
Pageof 177